Category: Vaccine

Page 136«..1020..135136137138..150160..»

Keeping Preventable Diseases At Bay in Nigeria – Gavi, the Vaccine Alliance

November 29, 2023

Throughout the COVID-19 pandemic, Public Health Specialist Lucy Pam Dangyang endeavored to bring vaccines to hard-to-reach communities in the Riyom and Kanam local government areas of Nigeria's Plateau State. The goal for the 25-year-immunization veteran: bringing both COVID-19 vaccines along with routine immunizations to areas that had not received vaccines before. The effort, she recalls now, was her proudest professional accomplishment to date, as it was the first time she reached and vaccinated zero-dose children. "I was so happy because that was the first time [the community members] were able to accept vaccination," she says.

In the wake of COVID-19, however, Lucy noticed that many children born during the height of the pandemic missed out on routine childhood immunizations. This led to a diphtheria outbreak in the country, she says, and she has also encountered increasing amounts of young children with measles. "I find out that in communities where you find poor surveillance activities, you will see a gap [in] routine immunization."

So Lucy enrolled in the firstCOVID-19 Recovery for Routine Immunization Programs Fellowship, a joint program from Sabin Vaccine Institute and the World Health Organization to support those attempting to catch up communities that fell behind on immunizations during the pandemic. The program inspired her to design a catch-up vaccination plan addressing hard-to-reach rural populations, including one community in particular lives on a mountain that is difficult to get to, especially considering the limited number of health workers in the area.

Lucy and her team have found success by integrating routine vaccination and COVID-19 vaccination services together with other health services, such as tuberculosis testing. When people come for tuberculosis testing, including mothers with babies, she says they end up being vaccinated while they are being tested. "Any opportunity we have, we want to integrate all these activities at the same time."

Those opportunities include setting up routine immunization activities at gathering sites like churches and mosques. Lucy and her team first meet with the religious leaders and ask for time to do some awareness-building during services. Then the team is able to conduct immunization activities afterwards. "The religious leaders, who we call the stakeholders, are a role model, in the sense that they will come up and volunteer to get the vaccine, like COVID-19. Then others will follow and get vaccinated."

Lucy has been determined to reach zero-dose children since the early days in her career as a nurse working at a university teaching hospital and seeing young babies die of vaccine-preventable diseases. "It wasn't good. It is an experience that will make somebody, as a mother, want to try and help other children." She went on to earn a master's degree in epidemiology "so that I can know the intricacies of the diseases."

Today Lucy continues her efforts to reach zero-dose children and has contributed to preparations for the recent roll-out of the human papilloma virus (HPV) vaccine for adolescent girls in Nigeria. Vaccine hesitancy, she says, is a continuing issue. "When we have a new vaccine, there's always a lot of hesitancy, a lot of rumors, like it will reduce your lifespan or cause sterility." She hopes to incorporate HPV vaccine introduction into her catch-up immunization plan.

Lucy joined Sabin's online Boost Community for immunization professional development this year, and says she is grateful for the continuing knowledge and support she gains through Boost. "Boost has really helped me to raise awareness [about] vaccination. When you have knowledge of something, you'll be bold to speak on it to raise awareness in the community through their engagement."

This article was originally published by Sabin Vaccine Institute on 15 November 2023.

Read the rest here:

Keeping Preventable Diseases At Bay in Nigeria - Gavi, the Vaccine Alliance

Pet vaccine hesitancy is founded | Letters to the Editor … – Citrus County Chronicle

November 29, 2023

State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. West Virginia Wisconsin Wyoming Puerto Rico US Virgin Islands Armed Forces Americas Armed Forces Pacific Armed Forces Europe Northern Mariana Islands Marshall Islands American Samoa Federated States of Micronesia Guam Palau Alberta, Canada British Columbia, Canada Manitoba, Canada New Brunswick, Canada Newfoundland, Canada Nova Scotia, Canada Northwest Territories, Canada Nunavut, Canada Ontario, Canada Prince Edward Island, Canada Quebec, Canada Saskatchewan, Canada Yukon Territory, Canada

Zip Code

Country United States of America US Virgin Islands United States Minor Outlying Islands Canada Mexico, United Mexican States Bahamas, Commonwealth of the Cuba, Republic of Dominican Republic Haiti, Republic of Jamaica Afghanistan Albania, People's Socialist Republic of Algeria, People's Democratic Republic of American Samoa Andorra, Principality of Angola, Republic of Anguilla Antarctica (the territory South of 60 deg S) Antigua and Barbuda Argentina, Argentine Republic Armenia Aruba Australia, Commonwealth of Austria, Republic of Azerbaijan, Republic of Bahrain, Kingdom of Bangladesh, People's Republic of Barbados Belarus Belgium, Kingdom of Belize Benin, People's Republic of Bermuda Bhutan, Kingdom of Bolivia, Republic of Bosnia and Herzegovina Botswana, Republic of Bouvet Island (Bouvetoya) Brazil, Federative Republic of British Indian Ocean Territory (Chagos Archipelago) British Virgin Islands Brunei Darussalam Bulgaria, People's Republic of Burkina Faso Burundi, Republic of Cambodia, Kingdom of Cameroon, United Republic of Cape Verde, Republic of Cayman Islands Central African Republic Chad, Republic of Chile, Republic of China, People's Republic of Christmas Island Cocos (Keeling) Islands Colombia, Republic of Comoros, Union of the Congo, Democratic Republic of Congo, People's Republic of Cook Islands Costa Rica, Republic of Cote D'Ivoire, Ivory Coast, Republic of the Cyprus, Republic of Czech Republic Denmark, Kingdom of Djibouti, Republic of Dominica, Commonwealth of Ecuador, Republic of Egypt, Arab Republic of El Salvador, Republic of Equatorial Guinea, Republic of Eritrea Estonia Ethiopia Faeroe Islands Falkland Islands (Malvinas) Fiji, Republic of the Fiji Islands Finland, Republic of France, French Republic French Guiana French Polynesia French Southern Territories Gabon, Gabonese Republic Gambia, Republic of the Georgia Germany Ghana, Republic of Gibraltar Greece, Hellenic Republic Greenland Grenada Guadaloupe Guam Guatemala, Republic of Guinea, Revolutionary People's Rep'c of Guinea-Bissau, Republic of Guyana, Republic of Heard and McDonald Islands Holy See (Vatican City State) Honduras, Republic of Hong Kong, Special Administrative Region of China Hrvatska (Croatia) Hungary, Hungarian People's Republic Iceland, Republic of India, Republic of Indonesia, Republic of Iran, Islamic Republic of Iraq, Republic of Ireland Israel, State of Italy, Italian Republic Japan Jordan, Hashemite Kingdom of Kazakhstan, Republic of Kenya, Republic of Kiribati, Republic of Korea, Democratic People's Republic of Korea, Republic of Kuwait, State of Kyrgyz Republic Lao People's Democratic Republic Latvia Lebanon, Lebanese Republic Lesotho, Kingdom of Liberia, Republic of Libyan Arab Jamahiriya Liechtenstein, Principality of Lithuania Luxembourg, Grand Duchy of Macao, Special Administrative Region of China Macedonia, the former Yugoslav Republic of Madagascar, Republic of Malawi, Republic of Malaysia Maldives, Republic of Mali, Republic of Malta, Republic of Marshall Islands Martinique Mauritania, Islamic Republic of Mauritius Mayotte Micronesia, Federated States of Moldova, Republic of Monaco, Principality of Mongolia, Mongolian People's Republic Montserrat Morocco, Kingdom of Mozambique, People's Republic of Myanmar Namibia Nauru, Republic of Nepal, Kingdom of Netherlands Antilles Netherlands, Kingdom of the New Caledonia New Zealand Nicaragua, Republic of Niger, Republic of the Nigeria, Federal Republic of Niue, Republic of Norfolk Island Northern Mariana Islands Norway, Kingdom of Oman, Sultanate of Pakistan, Islamic Republic of Palau Palestinian Territory, Occupied Panama, Republic of Papua New Guinea Paraguay, Republic of Peru, Republic of Philippines, Republic of the Pitcairn Island Poland, Polish People's Republic Portugal, Portuguese Republic Puerto Rico Qatar, State of Reunion Romania, Socialist Republic of Russian Federation Rwanda, Rwandese Republic Samoa, Independent State of San Marino, Republic of Sao Tome and Principe, Democratic Republic of Saudi Arabia, Kingdom of Senegal, Republic of Serbia and Montenegro Seychelles, Republic of Sierra Leone, Republic of Singapore, Republic of Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia, Somali Republic South Africa, Republic of South Georgia and the South Sandwich Islands Spain, Spanish State Sri Lanka, Democratic Socialist Republic of St. Helena St. Kitts and Nevis St. Lucia St. Pierre and Miquelon St. Vincent and the Grenadines Sudan, Democratic Republic of the Suriname, Republic of Svalbard & Jan Mayen Islands Swaziland, Kingdom of Sweden, Kingdom of Switzerland, Swiss Confederation Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand, Kingdom of Timor-Leste, Democratic Republic of Togo, Togolese Republic Tokelau (Tokelau Islands) Tonga, Kingdom of Trinidad and Tobago, Republic of Tunisia, Republic of Turkey, Republic of Turkmenistan Turks and Caicos Islands Tuvalu Uganda, Republic of Ukraine United Arab Emirates United Kingdom of Great Britain & N. Ireland Uruguay, Eastern Republic of Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam, Socialist Republic of Wallis and Futuna Islands Western Sahara Yemen Zambia, Republic of Zimbabwe

More:

Pet vaccine hesitancy is founded | Letters to the Editor ... - Citrus County Chronicle

Vaccination Status of Patients with Hematologic Malignancies Not … – Pharmacy Times

November 29, 2023

COVID-19 booster vaccines were introduced to improve the efficacy of vaccinations; however, the success varied across patients with hematologic malignancies. Further, the Omicron variant puts individuals at a higher risk for contracting COVID-19 because of its higher infection rate. A study published in Cancer Medicine evaluated the outcomes of patients with hematologic malignancies during the COVID-19 Omicron outbreak, and how the availability of vaccine boosters and antiviral treatments would impact the patients outcomes.

Image credit: Zoran Zeremski | stock.adobe.com

This retrospective study included patients 18 years of age and older with hematologic malignancies (e.g., lymphoma, plasma cell neoplasms, etc.) during the Omicron outbreak, with data collection starting January 2022. They enrolled 116 patients with hematologic malignancies who were recruited from 2 medical centers and had to have a COVID-19 diagnosis confirmed by a real-time polymerase chain reaction (PCR) test or an institutional supervised rapid antigen test. Further, the majority of enrolled patients (n = 106; 91%) were vaccinated with the BNT162b2 mRNA vaccine, with 2, 3, and 4 doses in 12%, 44%, and 33% of patients, respectively.

Hematologic diagnoses included both lymphoma (non-Hodgkin and Hodgkin lymphoma; n = 33, 28%), chronic lymphocytic leukemia (CLL; n = 22, 19%), plasma cell neoplasms (n = 24, 21%), and myeloid neoplasms (n = 37, 32%). Approximately 80% of patients reported 1 or more comorbidities, the most common being hypertension (49%), cardiovascular disease (19%), and diabetes mellitus (16%). At the time of their COVID-19 diagnoses, 13% of patients were treatment-nave, 61% were on active hematologic treatment, and 30% were previously treated for their hematologic diseases.

In addition, 78% of patients contracted COVID-19 between January and February 2022, and the remaining 22% contracted COVID-19 between March and April 2022. Further, severe COVID-19 cases were reported only during the first period, with 2 patients being hospitalized due to their COVID-19 infection. Severe COVID-19 infection was commonly associated with older age (>65 years of age), more than 1 comorbidity, and cardiovascular disease. Patients with CLL had a higher risk of developing severe COVID-19, whereas patients with myeloid neoplasms had the lowest risk. Approximately 26% of patients who were receiving active treatment for their hematologic malignancies had to pause treatment at the time of their COVID-19 infection, with the median time off being 10 days (range: 7 to 14 days).

There were no recorded associations between severe COVID-19 infection and vaccination status (vaccinated compared to unvaccinated) or the number of given doses (up to 2 vs 3 and 4 doses); however, patients who had received a vaccine dose between 7 and 90 days prior to COVID-19 infection were significantly less likely to develop severe COVID-19 infection. Further, antiviral COVID-19 therapies were given to approximately 44% of patients. Administration occurred within 5 days of infection onset in high-risk patients, and treatments included nirmatrelvir and ritonavir (n = 35; 69%), molnupiravir (n = 13; 25%), and short-course remdesivir (n = 3, 6%).

The investigators note that active hematologic treatment or specific treatment groups were not correlated with COVID-19 severity. In addition, no association was seen between severe COVID-19 infection and exposure to anti-CD20 antibodies, and according to the study authors, this finding is similar to prior research conducted during the Omicron outbreak. In addition, the potential reason for a lack of association between anti-CD20 therapy and COVID-19 infection during the Omicron outbreak could be a sustained response from vaccine administration prior to the initiation of therapy combined with preserved cellular response.

A limitation of the study is the small sample size, as it could have affected the investigators ability to detect more significant findings. Further, the authors note that the severity of hematologic outcomes, although noted prior to COVID-19 infection, could be an additional adverse effect of COVID-19 infection. The authors note that a 3-month period of increased vaccine efficacy can assist when determining the ideal timing for re-vaccination in high-risk populations.

Reference

Gutwein, O,Herzog K,Apel, A, et al.Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.Cancer Med.2023;00:1-8. doi:10.1002/cam4.6397

Here is the original post:

Vaccination Status of Patients with Hematologic Malignancies Not ... - Pharmacy Times

What you need to know about COVID and vaccines now – Sydney Morning Herald

November 25, 2023

Released on Thursday, the data shows a 16 per cent increase in community infections in the fortnight to November 18, compared with the previous reporting period, for those who have tested positive for COVID-19 via PCR testing.

Since the beginning of October, COVID-19 numbers have increased by 94 per cent. NSW Health releases its epidemiological report only fortnightly.

The total number of people presenting at emergency departments in the past fortnight was also higher than for the previous two weeks, NSW Health said, but the proportion who required admission remained stable, indicating that the severity of the virus circulating in the community remained unchanged.

Self-reporting of COVID-19 positive RAT results ceased at the end of September, with authorities turning to the NSW Sewerage Surveillance Program to test fragments on SARS-CoV-2, to gain an insight into virus spread. The latest data indicates the concentration of COVID-19 in Bondi, Liverpool and Quakers Hill is higher than in other parts of Sydney and rising.

Rising rates of COVID detected in Sydneys wastewater (black line). NSW Health

The variant EG.5 now accounts for more than half of all variants in the state, but the proportion of samples in which BA.2.86 has been detected is increasing.

The nations emergency response to the pandemic formally ended on October 20, with the countrys chief health officer declaring that there was no longer a need for the virus to be considered a communicable disease incident of national significance.

following approval by the Australian Technical Advisory Group on Immunisation (ATAGI).

The new XBB.1.5. vaccines target a sub-variant of the Omicron strain and have been approved for use as both primary and additional doses, with Pfizers version approved for eligible people aged over five years, and Modernas for those over 12.

The vaccines offer modestly improved protection against COVID-19 strains circulating in Australia, according to a federal government statement.

Kirby Institutess Associate Professor Stuart Turville. James Brickwood

University of NSW Associate Professor Stuart Turville, who works out of the Kirby Institute, said that while the new vaccines were not specific to EG5, EG5 and XBB.1.5, they were very closely related and the vaccines would offer significant benefits.

A dynamic of our immune system is that it is often better the longer you leave it [to get a booster]. There have been studies done that have shown if you have a really short distance between your booster, it doesnt offer the best protection, he explained.

A lot of people naively think I need to have a booster every three months, or I need to have (a booster at the) distance that is available to me because they think that keeping the antibodies up is the best thing.

But what protects you the best is that you give your body a break, and what that does is it cools the jets a bit, and then your immune cells actually beautifully mature over that time, and then you are producing quality rather than quantity, and the antibodies left actually do a really, really good job.

ATAGI does not, at this stage, recommend a second 2023 booster for healthy people under 65.

Turville said that ATAGIs vaccine advice was fluid and encouraged individuals to monitor for any changes.

He added that while COVID-19 may no longer be front page news, there was a lot of scientific activity in the background surveilling what the virus was doing.

People need to be confident that there are really smart measures that we have learnt over the last three years that are consolidated, and theyre very sharp and purposeful, to feedback to us so we understand what the virus is doing, Turville said.

Oral antiviral treatments Lagevrio and Paxlovid remain approved for people who are vulnerable to severe disease as they can help slow COVID-19 infections.

The federal government recommends that those eligible start antivirals as soon as possible after symptoms begin. The advice has not been updated since July.

Those who may be eligible for PBS-subsidised antiviral medication are people over 70 years of age, those who are 50 and who have a comorbidity, as well as First Nations people over 30 who have one additional risk factor for developing severe disease.

People who are severely immunocompromised, and who are over 18, are also eligible for antiviral medication. These include people who have blood cancer, who are a transplant recipient, who have undergone chemotherapy or radiotherapy in the past three months, who have congenital heart disease or who have cerebral palsy or Down Syndrome.

The Morning Edition newsletter is our guide to the days most important and interesting stories, analysis and insights. .

Read the original:

What you need to know about COVID and vaccines now - Sydney Morning Herald

Burying the fallacy of vaccine sceptics – Hindustan Times

November 25, 2023

Nov 22, 2023 10:43 PM IST

An Indian Council of Medical Research (ICMR) study has found that the spate of sudden deaths reported post-Covid among young adults in India could be because of past Covid hospitalisation, family history of sudden deaths, binge drinking, and intense unaccustomed activity. It should set at rest the harmful narrative based on anecdotes and rumours that Covid-19 vaccines caused these deaths.

Covid-19 was first reported in late 2019, infected hundreds of millions of people, caused close to seven million deaths and led to economic distress across the world. Scientists developed vaccines within a few months of the outbreak. These vaccines saved the lives of hundreds of millions of people. However, vaccine sceptics have been picking on random deaths and listing anecdotal evidence to campaign against Covid-19 vaccines. This defamation campaign had sought to blame the many sudden deaths as the outcome of Covid-19 vaccines.

The ICMR study is a good beginning that debunks such campaigns with peer-reviewed scientific evidence. Our response to diseases has to be based on scientific evidence. Science has to be the guiding light of public policy. India has one of the worlds largest vaccination programmes. Once common diseases such as smallpox, measles, and polio have been brought under control with vaccines. Yet, there is a high prevalence of vaccine hesitancy in the country. Indias challenge is to bring more and more people under the ambit of vaccination. The pharma industry may try to influence health policy, but that is a matter of regulation and oversight, not a reason to discredit or deny vaccines.

An Indian Council of Medical Research (ICMR) study has found that the spate of sudden deaths reported post-Covid among young adults in India could be because of past Covid hospitalisation, family history of sudden deaths, binge drinking, and intense unaccustomed activity. It should set at rest the harmful narrative based on anecdotes and rumours that Covid-19 vaccines caused these deaths.

Covid-19 was first reported in late 2019, infected hundreds of millions of people, caused close to seven million deaths and led to economic distress across the world. Scientists developed vaccines within a few months of the outbreak. These vaccines saved the lives of hundreds of millions of people. However, vaccine sceptics have been picking on random deaths and listing anecdotal evidence to campaign against Covid-19 vaccines. This defamation campaign had sought to blame the many sudden deaths as the outcome of Covid-19 vaccines.

The ICMR study is a good beginning that debunks such campaigns with peer-reviewed scientific evidence. Our response to diseases has to be based on scientific evidence. Science has to be the guiding light of public policy. India has one of the worlds largest vaccination programmes. Once common diseases such as smallpox, measles, and polio have been brought under control with vaccines. Yet, there is a high prevalence of vaccine hesitancy in the country. Indias challenge is to bring more and more people under the ambit of vaccination. The pharma industry may try to influence health policy, but that is a matter of regulation and oversight, not a reason to discredit or deny vaccines.

Daily E Paper I Premium Articles I Brunch E Magazine I Daily Infographics

See more here:

Burying the fallacy of vaccine sceptics - Hindustan Times

COVID vaccines went ‘on trial.’ Are routine childhood vaccine mandates at risk? – Bulletin of the Atomic Scientists

November 25, 2023

A vaccine protest in 2021. Credit: Anthony Crider via Wikimedia Commons. CC BY 2.0.

Vaccines, one of the greatest public health achievements of the 20th century, proved their worth, yet again, in response to one of the greatest infectious disease threats of all time: COVID-19. Approximately 70 percent of Americans completed the original primary series of COVID vaccines, helping to restart the global economy and allow people to escape social isolation. These vaccines prevented an estimated 3.2 million deaths nationally between December 2020 and November 2022. Millions more were spared the risks of extensive hospital stays, extended illness from long-COVID, and other substantial harms. Earlier this year, researchers contributing to the science underlying the vaccines were awarded a Nobel Prize.

Despite this positive track record, significant skepticism remains about COVID and other vaccines. Scores of Americans refused to get vaccinated during the pandemic despite strong incentives and clear dangers to their and their families health, a trend that has intensified in recent years. Just 17 percent of Americans received the critical omicron booster shot offered in late 2022. Considerably fewer (7.1 percent of adults and 2.1 percent of children as of October 14) have sought the updated COVID vaccines that became available this fall. One of the most contentious pandemic-era debatesfueled by apathy, safety concerns, misinformation, and government distrustinvolves the use of vaccine mandates by governments, schools, and employers to boost COVID vaccination rates.

Although the United States has a long-standing and legally supported history of vaccination requirements in certain contexts, the COVID pandemic witnessed scores of lawsuits challenging them, as political and media figures vilified vaccination and other public health measures. These lawsuits touched on constitutional issues and statutory concerns, with plaintiffs seeking exemptions or an end to mandate enforcement altogether. And while several states have moved to further restrict or eliminate vaccine mandates, the Supreme Court has opened the door to increased challenges under the Civil Rights Act, which may heighten exemptions that could undermine the efficacy of vaccine efforts. COVIDs tidal wave of lawsuits, state legislation, and vaccine skepticism evince an environment where vaccines are truly on trial.

COVID-19 vaccine incentives and mandates. With the issuance of multiple emergency use authorizations by the Food and Drug Administration beginning in December 2020, initial COVID vaccines were allocated first to at-risk health care workers and then to others over several priority stages. By February 2021, Americans were waiting in long lines at stadiums and other centralized sites across many US cities, vying for access to free COVID vaccines. The initial push for access to the shots quickly waned. Even as available supplies rose, the numbers of Americans actively seeking vaccinations plummeted by spring, before most communities reached anything close to herd immunity.

In response, the public and private sectors pivoted rapidly to reverse growing public apathy and resistance to vaccinations. Raffles, lotteries, gift cards, college scholarships, travel vouchers, and even free beer, doughnuts, and marijuana were offered to entice individuals across states and localities to get vaccinated. So long as they are equitably distributed, such incentives are lawful and can work. A 2023 systematic review confirmed that financial rewards positively impacted personal decisions to get vaccinated.

Yet, incentives alone were not enough to sufficiently raise vaccination rates. Governments and private employers turned increasingly in 2021 to mandates (coupled with optional test requirements) to garner compliance among employees, students, health care workers, and others. For over a century, states and localities have authorized vaccine mandates as a condition of participation in work, school, or other activities. The Supreme Court has largely approved non-forcible vaccine requirements since 1905. These measures have proven effective, especially during disease outbreaks or pandemics.

During the COVID pandemic, states and localities set numerous COVID vaccine requirements. Hundreds of colleges and universities mandated vaccination for on-campus faculty and students during the 2021-2022 academic year. Secondary and elementary school teachers and students in multiple jurisdictions were inoculated or regularly tested. Higher-profile mandates arose as well. By September 2021, President Joe Biden announced a series of measures requiring COVID vaccination for federal employees/contractors, military service personnel, health care providers, large company employees, and select federally funded educators.

Judicial challenges. Through extensive lawsuits challenging these and other COVID vaccine mandates, litigants alleged violations of their bodily autonomy, privacy, religious freedoms, philosophical beliefs, and rights to refuse medical treatment. Initially, most courts spurned these constitutional challenges, in light of historical legal support for mandates and the sheer public health threat posed by the pandemic. According to one source, between April and October 2021, 30 courts refused to block vaccine mandates.

In one closely watched case, a federal judge in July 2021 approved Indiana Universitys broad vaccine mandate affecting students and faculty to protect the publics health. The plaintiffs appealed the decision to the Supreme Court, which turned away a chance to review and overturn the decision.

In select cases, however, courts rejected governmental and private sector policies requiring COVID vaccines. Some judges expressly disdained vaccine mandates that disallowed exemptions, largely on grounds of perceived infringements of religious freedoms.

In January 2022, the Supreme Court struck down the Occupational Health and Safety Administrations vaccinate-or-test requirement for large employers. At the same time, the Court upheld a separate federal mandate requiring vaccinations for health care workers. This mandate was required for health care facilities to continue receiving funding from the Centers for Medicare and Medicaid Services. As such, the Court ruled it was an acceptable exercise of the governments federal spending powers. In the case of the large-employer mandate, however, the Court determined that the government had overstepped its authority to regulate interstate activities. To date, the Court continues to ponder the constitutionality of Bidens federal contractor mandate even though the national public health emergency sustaining it was voluntarily lifted in May 2023.

Exemptions. Even where mandates remain intact, their continued effectiveness depends on compliance, and that compliance rate has recently been dropping. The Centers for Disease Control and Prevention and the Equal Employment Opportunity Commission (EEOC) have documented precipitous increases of Americans claiming religious or non-medical exemptions. Some challengers argue for exemptions from governmental vaccine mandates pursuant to the First Amendments free exercise of religion clause.

Neither the Supreme Court nor most lower courts specifically recognize a constitutional guarantee to religious exemptions from neutral and generally applicable vaccine mandates. Generally, the Court considers a law to be neutral when it does not target religion specifically. Recently, it has signaled that vaccine mandates providing medical exemptions, but not religious ones, may not be considered neutral, which could lead to stricter scrutiny.

While the Court has not directly reviewed a case asserting constitutional free-exercise-of-religion arguments against mandates, a ruling this past June could open the door to further exemptions on statutory grounds. In Groff v. DeJoy, which involved an evangelical Christian postal service employee who did not believe in working on Sundays, the Court clarified requirements under Title VII of the federal Civil Rights Act. Under the law, employers must offer employees religious accommodations that are not unduly burdensome. Though not specifically about vaccine mandates, the Courts conclusion substantially raised the bar on what actually constitutes an undue burden for employers, complicating employee adherence to mandates in the future, especially in nursing and other health care sectors. Already, in September 2023, the Equal Employment Opportunity Commission filed two lawsuits alleging that employers had failed to properly accommodate employees seeking exemptions from their employers COVID vaccine policies.

Absent affirmative First Amendment protections requiring religious exemptions, governments can ignore or eliminate broad religious exemptions without tripping federal constitutional requirements. In 2021, Connecticut joined five other states offering no religious exemptions to school vaccine requirements, immediately engendering litigation. In August 2023, the federal Court of Appeals for the Second Circuit dismissed free exercise challenges to Connecticuts law, although additional claims are proceeding.

In other states, court rulings or laws are expanding exemptions. In April 2023, a federal court required Mississippi to allow religious exemptions from school vaccination requirements. For decades, the state had among the highest state vaccination rates among school-aged children, in part owing to its limited exemptions. Such rates may decline in the years ahead based on this decision.

Shifting vaccine attitudes. Judicial treatment of COVID mandates partly reflects shifting national views over vaccinations generally. Skeptical attitudes furthered by influential, well-funded anti-vaccine efforts contributed to legislative reforms, as well.

During the pandemic, elected representatives in key vaccine-adverse jurisdictions introduced and passed legislation banning private businesses, and even state and local governments, from requiring COVID vaccinations. By the end of June 2023, 26 states had legislatively limited COVID vaccine mandates.

Negative assessments in many states have not been limited to COVID public health measures. Some jurisdictions are re-assessing long-standing school vaccination requirements, enacting legislation to make exemptions easier. For decades, all states have conditioned school attendance on meeting a full schedule of childhood vaccinations. Courts have routinely authorized employer vaccine mandates, especially in the health care sector. These public health laws are now under attack. Montanas legislature attempted to ban vaccine mandates, excepting pre-existing school requirements, until a federal court found the measure unconstitutional in late 2022. Earlier this month, Texas Governor Greg Abbott signed the Vaccine Freedom Bill prohibiting mandates by private employers.

National attitudes, adverse public health laws, and judicial decisions are chipping away at one-time solid childhood vaccine rates. Only 65 percent of parents in December 2022 believed healthy children should be required to be vaccinated against measles, mumps, and rubella (MMR) to attend school, down from 76 percent in October 2019. In November 2023, the CDC reported that US parents seeking exemptions from childhood vaccine requirements during the 2022-2023 school year reached the highest level ever. National averages for school vaccinations plateaued at approximately 93 percent this past year, which is sufficiently below recommended compliance levels. Consequently, new vaccine-preventable disease outbreaks among schoolchildren are virtually assured.

Ongoing legal and policy challenges around vaccinations unnecessarily threaten the health of children, patients, workers, and communities overall. Legislatures or courts broadening vaccine exemptions is specious. Rescinding long-standing vaccine mandates on grounds of personal autonomy, misinformation, and governmental distrust is indefensible.

Efficacious vaccinations allocated fairly and administered safely are indispensable to reducing death and illness tied to emerging infectious diseases. With routine contagions like measles, mumps, and rubella making comebacks, advanced strains of COVID and annual flu re-surfacing, and new, emerging infectious conditions always on the horizon, legal and political rejection of vaccine mandates and greater allowances of exemptions are antithetical to proven public health practices.

The rest is here:

COVID vaccines went 'on trial.' Are routine childhood vaccine mandates at risk? - Bulletin of the Atomic Scientists

NOT REAL NEWS: A look at what didn’t happen this week – Yahoo News

November 25, 2023

A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts:

___

No evidence that DNA sequence used in Pfizer shot leads to cancer and other health issues

CLAIM: Pfizers COVID-19 vaccine contains a DNA sequence called Simian Virus 40 that can cause health problems, including cancer.

THE FACTS: No evidence has been found to suggest DNA fragments used in the development of the coronavirus vaccine -- such as a portion of SV40s DNA sequence -- are causing health problems in people who have received the COVID-19 vaccine. A recent congressional hearing r evived the baseless claim that coronavirus vaccines contain dangerous levels of monkey virus DNA. Following the hearing, social media users began sharing a post with information from The Epoch Times website that reported Congress was warned at the hearing about DNA fragments detected in the inoculation made by Pfizer and BioNTech. The post cites testimony from Dr. Robert Malone, who played a role in developing the messenger RNA, or mRNA, technology used in the vaccine, claiming the shot includes a DNA sequence called Simian Virus 40, or SV40. The sequence leaves behind residual DNA that could cause problems, reads one Instagram post. But the Nov. 13 hearing at the U.S. Capitol, which was held by Rep. Marjorie Taylor Greene and other vaccine critics in the House of Representatives, repeated long-debunked falsehoods about the contents of the shot and purported health risks like cancer. Government regulatory agencies and vaccine experts told The Associated Press that the Simian Virus itself isnt present in the vaccine, and theres no evidence anything contained in the vaccine could alter a persons DNA or lead to cancer and other illnesses. The European Medicines Agency, which regulates vaccines in European Union nations, explained that non-functional fragments of SV40s DNA sequence are used as starting material in producing the vaccine. But theyre mostly being broken down and removed in the manufacturing process. Trace amounts might remain at very low levels in the final product, the agency and others acknowledged, but they are well within established safety guidelines. EMA has seen no evidence of an association between mRNA vaccines and adverse events that could be linked to the presence of DNA material, nor are we aware of any scientific evidence showing that the very small amounts of residual DNA that may be present in vaccine batches could integrate into the DNA of vaccinated individuals, the Amsterdam-based agency wrote in an emailed statement. The Food and Drug Administration, which regulates vaccines in the U.S., echoed the sentiment, saying no safety concerns about residual DNA in COVID vaccines have been identified, despite more than one billion shots being administered. The FDA stands behind its findings of quality, safety, and efficacy for the mRNA vaccines, the agency wrote, deferring further questions to Pfizer and other vaccine makers. Pfizer, in an emailed statement, stressed that the use of the SV40 sequence is common practice in developing vaccines, including the influenza and hepatitis shots that have been administered globally for decades. There is no evidence to support claims that the Pfizer-BioNTech COVID-19 vaccine contains plasmid DNA that could potentially impact a persons DNA or be a theoretical cancer risk, the company wrote, referring to DNA materials used to trigger an immune response during vaccine development. Spokespersons for The Epoch Times didnt respond to messages seeking comment.

-Associated Press writer Philip Marcelo in New York contributed this report.

___

Newly released Jan. 6 footage does not show a federal agent flashing his badge while undercover

CLAIM: Security camera footage from Jan. 6, 2021, shows a federal agent disguised as a supporter of then-President Donald Trump during the attack on the U.S. Capitol.

THE FACTS: The man in the video is not a federal agent. It's Kevin James Lyons, a Chicago man who was sentenced in July to more than four years in federal prison for his role in the attack. Multiple images of Lyons at the Capitol, dressed as he is in the footage, appear in court documents. The false claim emerged after House Speaker Mike Johnson on Nov. 17 began releasing thousands of hours of footage from the Capitol insurrection. Social media users including members of Congress seized on a clip saying it proved that undercover federal agents participated in the riot. The video, which is 5 minutes and 31 seconds long, shows rioters and law enforcement personnel moving through a hallway in the Capitol. At 21 seconds into the video, a man appears from behind a column wearing a red Make America Great Again hat, a camouflage scarf covering most of his face, and a dark blue sweatshirt layered over a green sweatshirt. He walks toward the camera, flashing his palms at the 36-second mark with a small object in his right hand. And that ladies and gentlemen is a badge with a red hat and fully disguised, reads one post on X that shared a screenshot of the footage paused as Lyons is flashing his palms. But these claims play on enduring conspiracytheories about federal agents orchestrating the events of Jan. 6. Lyons was sentenced on July 14 to 51 months in federal prison for the part he played in the riot. Court documents include multiple images of Lyons inside the Capitol, dressed in the same outfit as in the security footage. For example, one shows Lyons recording himself in a mirror in the office of then-Speaker Nancy Pelosi. In another, he sits in a car holding a framed photograph from Pelosis office, which shows her with the late Congressman John Lewis, a civil rights movement icon who died in July 2020. It is unclear exactly what Lyons is holding in his right hand when he flashes his palms. Lyons was convicted in April of six charges, including obstruction of an official proceeding. In addition to prison time, he was ordered to pay $2,000 in restitution to the Architect of the Capitol and complete 36 months of supervised release. Johnson on Friday publicly released about 90 hours of security footage from the Jan. 6 attack. An additional 44,000 hours is expected to be posted online over the next several months, the AP has reported.

- Associated Press reporter Melissa Goldin in New York contributed this report. ___

Video shows Israeli soldiers raising a flag over a Gaza school building, not a hospital

CLAIM: A video shows Israeli soldiers placing a flag atop Gazas Shifa Hospital.

THE FACTS: The video shows the soldiers raising the countrys flag over a United Nations-operated school in the city, not the hospital, a U.N. agency spokesperson confirmed. But posts online misrepresent the footage,,saying the video was taken at Gazas largest hospital, which became a focal point in the latest conflict between Israel and Hamas this month. In the video, three soldiers walk along a flat rooftop carrying a flagpole bearing the Israeli flag and its distinctive Star of David, along with another purple and white flag. The group, dressed in heavy military gear, silently affixes the pole to a short column along the edge of the roof before quickly walking away. They set up their flag on top of the Al Shifa Hospital To congratulate themselves on conquering a place filled with premature babies, injured kids and dead woman, the text on the brief clip reads. But the flag wasnt raised at Shifa Hospital which Israel raided last week, claiming it hid a command center for Hamas but at a school elsewhere in the city. Juliette Touma, a spokesperson for the U.N.s Relief and Works Agency for Palestine Refugees in the Near East, confirmed in an email Tuesday that the building shown in the video houses one of its schools in the Hamas-controlled Gaza City. Indeed, at one point in the video, the three soldiers step over the letters UN written in large dark-colored capital letters on the rooftop floor. But Touma declined to say which of the more than 180 schools the agency operates in the Gaza Strip is shown in the video. She also said it was unclear when the flag was raised or whether or not its still there. This is what we have for now and we dont have more details, Touma wrote. Spokespersons for the Israeli government and military didnt respond to emails seeking comment. But the video appears to have been taken from the roof of a school building at the intersection of Tariq Ibn Ziyad and Al-Naser roads, which is located about one mile from the hospital. Satellite imagery on Google Earth shows the letters UN painted on the long flat roof of one building, and matches several distinctly-styled structures that are shown in the video surrounding the campus complex that includes at least four schools for boys. For example, at the beginning of the clip, a tower with a red roof and a tall antenna on top can be seen in the upper left of the clip. That matches a building a block away on the map. Another building in front of the soldiers as they plant the flag has a unique curved facade and window on the top level, which is also visible in the satellite image. Its unclear who first shared the video, but Israeli journalist Hallel Bitton Rosen shared a longer, clearer version of the footage on his social media accounts on Nov. 15. Rosen, who didnt respond to emails seeking comment, described the clip in a post written in Hebrew as showing soldiers from the Israeli militarys Givati Brigade raising a flag atop a school. The Givati Brigade is composed of infantry units and has a purple and white flag similar to the one flown along with the Israeli flag in the video.

- Philip Marcelo

___

Video misrepresents Bidens departure from White House turkey pardon

CLAIM: A video clip shows President Joe Biden abruptly leaving this years Thanksgiving turkey pardoning ceremony at the White House.

THE FACTS: In the full video of Mondays ceremony, Biden spends several minutes speaking and taking photos with guests after pardoning two turkeys in an address before hundreds of attendees. He can be seen waving to the crowd, plus giving a thumbs up and a salute, before leaving the event. But in the edited clip he leaves abruptly after the pardoning, turning away from the crowd and breaking into a light jog for a few moments before slowing to a walk as he makes his way to the White House. Two Marines standing in front of the door part to let him through and salute as he goes inside. Biden abruptly leaves his turkey pardon ceremony and half-jogs back inside, reads one post on X, formerly Twitter. In the full video from the ceremony, Biden makes a more prolonged departure from the South Lawn of the White House. Immediately after pardoning two turkeys, named Liberty and Bell, Biden can be seen speaking with Steve Lykken, chairman of the National Turkey Federation, and Jose Rojas, vice president of Jennie-O Turkey Store. Biden then speaks for several minutes with some of the hundreds of guests and p oses for photos. Finally, standing next to his granddaughter, Maisy Biden, the president waves to the crowd, giving a thumbs up and a salute, before making his exit. The tradition of pardoning turkeys dates back to 1947 when the National Turkey Federation, which represents turkey farmers and producers, first presented a National Thanksgiving Turkey to President Harry Truman.

- Melissa Goldin

___

Find AP Fact Checks here: https://apnews.com/APFactCheck

___

Follow @APFactCheck on Twitter: https://twitter.com/APFactCheck

Read more:

NOT REAL NEWS: A look at what didn't happen this week - Yahoo News

Vaccinations reduce the risk of long covid The Medical Republic – The Medical Republic

November 25, 2023

Being up to date with your boosters could cut the chances by three quarters or more, a major Swedish study suggests.

Three or more vaccinations reduce the risk of long covid by 73%, but even one or two doses appear to be protective.

A study of more than half a million Swedish adults with diagnosed covid found that having just one vaccine before their infection reduced the risk of long covid by 21% and having two reduced it by 59%.

The findings, based on data from 2020 to 2022, showed that long covid was fourfold higher in the unvaccinated group compared to those who had at least one jab.

The results of this study suggest a strong association between covid-19 vaccination before infection and reduced risk of receiving a diagnosis of PCC [post-covid-19 condition], the authors wrote in the BMJ.

The findings highlight the importance of primary vaccination against covid-19 to reduce the population burden of PCC.

While the benefits of vaccines against infection and severity is clear, its uncertain how effective they are against long covid.

The authors pointed to data showing one in 50 Swedish adults who were infected went on to be diagnosed with long covid, but other research based on self-reported symptoms suggest as many as half of all infected with covid have such issues.

This usually includes symptoms such as fatigue, dyspnoea, cognitive impairment, headaches, muscle pain, and heart abnormalities such as chest pain and palpitations.

In this study, the authors used a diagnosis of post-covid condition as the primary outcome.

Analysing the population-based database, the researchers found one vaccine dose was 19% effective against covid, two doses was 47% effective, and three or more doses was 58% effective.

Women were more likely than men to be vaccinated, as were older people compared with younger people. The chances of vaccinated people ending up in hospital were 1.5%, compared to 4% in the unvaccinated group.

Around 60% of the unvaccinated group was first infected during the Alpha wave, while 75% of the vaccinated group was infected during the Omicron wave.

When stratifying by the median time between last vaccination and infection (126 days) to assess the potential different effects of recent versus earlier vaccination, we found that receiving the last vaccine dose more than 126 days before covid-19 was still associated with a relatively high vaccine effectiveness against PCC, and only slightly lower than in the main analysis, the authors said.

In addition, to ensure sufficient time between vaccination and the acute infection, in a sensitivity analysis we restricted the vaccinated population to those who received their last vaccine dose more than 14 days before covid-19, and the estimated vaccine effect did not markedly change from the main analysis.

Furthermore, in the main analyses we only considered the first PCC diagnosis at least 28 days from infection, but in sensitivity analyses we required at least 90 days from infection, with similar results.

Their study did find that more than one in three patients with covid who went to the ICU were diagnosed with long covid.

Covid-19 vaccines have been shown to protect against hospital admission with covid-19, which could be one pathway for the vaccines to exert a protective effect against PCC, they wrote.

But reduced hospital admissions seemed to only account for part of this link, they said.

Analyses stratified on severity of acute disease as indicated by the need for hospital admission showed that vaccine effectiveness was similar in both the group admitted to hospital without ICU admission and the group with no hospital admission, the authors wrote.

But data suggested those vaccinated after the infection had a lower risk of developing long covid compared to adults vaccinated in the three months after their infection.

This, together with the findings in the present study, support the hypothesis of pathways beyond the protective effect against hospital admission that may contribute to the protective effect of covid-19 vaccines against PCC, the authors concluded.

BMJ 2023, online 16 October

Read the original:

Vaccinations reduce the risk of long covid The Medical Republic - The Medical Republic

We urge readers to update their COVID vaccinations for a healthy, holiday season | PennLive Editorial – PennLive

November 25, 2023

Were now full swing into the holiday season, and we wish we could say COVID 19 was in the rearview mirror. It isnt.

But COVID-19 is no longer the threat it once was when hospitals were full, thousands were clinging to life on ventilators and the morgues were chock full of bodies young and old.

Theres a reason COVID 19 and its variants are no longer the threat they once were. Its called vaccines.

For all the hoopla that surrounded COVID-19 vaccines when they first emerged, they have been a game changer for public health. If youre up to date on your COVID-19 vaccinations and boosters, you may still get the darn virus, but youre far more likely to survive.

This holiday season, COVID 19 is still prowling around look for new hosts. Its still sending people to the hospital, and it can still kill, especially if youre over 65 years old or suffer serious health conditions. But if youre fully vaccinated, even if you catch the virus, chances are good you wont wind up on a ventilator or worse.

With Moderna, Pfizer and Novavax, there now are enough vaccines readily available to anyone who wants to ward off serious illness and death. We owe a big debt to the hard-working doctors and scientists who worked to bring the vaccines safely to market and who continue to improve them, even as COVID mutates around us.

Those who prefer to take their chances with the latest strand of COVID this fall, and winter have the freedom to do so. Good luck and all the best to you. But why would anyone take the risk?

To ensure these holidays are filled with family and friends and not nurses and doctors, the vaccines are the key. The Center for Disease Control (CDC) is recommending everyone over the age of 5 get the 20232024 updated COVID-19 vaccines that hit the pharmacies in September. It doesnt matter if its Pfizer-BioNTech, Moderna, or Novavax, they all provide enough protection to keep most people out of the hospital.

By now if youve been paying the slighted attention, you know the COVID vaccine is no longer the only shot in town. You still need the annual flu vaccination. And people over 60 years old are advised to get the Respiratory Syncytial Virus (RSV) vaccine, as well.

RSV can be serious if youre over 60 years old or have celebrate one. In most other people, it causes mild, cold-like symptoms that are over in less than two weeks. But it can put older adults and infants in the hospital; and it can kill. Luckily, we can thank the scientists there are vaccines now available to protect older adults from severe

Again, its your call on whether to get the RSV vaccine if youre eligible, but why take the risk? Just get the shot when you get the other two and be done with it.

To prevent severe RSV disease in infants, the CDC recommends either maternal RSV vaccination or infant immunization. Its important for pregnant women to consults their physicians for individual guidance to protect their children.

The good news is this year we have options for a healthier holiday. Of course, you dont have to listen to the CDC, to the good doctors trying to keep you alive, or to us. But we urge you to do so.

Quality local journalism has never been more important. You deserve the best. Not a subscriber yet? Please consider supporting our work.

Follow this link:

We urge readers to update their COVID vaccinations for a healthy, holiday season | PennLive Editorial - PennLive

Which COVID Booster Should I Get? How To Choose Your Vaccine 2023 – Women’s Health

November 25, 2023

A lot has changed with

But even if youve mentally checked out from COVID-19 news for a bit, youre probably aware that the Food and Drug Administration recently approved and authorized updated COVID-19 vaccines. These vaccines are better designed to target the existing COVID-19 strains that are circulating than past versions of the shot, with the goal of offering you better protection. Basically, its a good idea to get one of them to lower the odds youll get sick and become seriously ill if you happen to get COVID-19.

Of course, were talking about a few vaccines to choose from. With that, its only natural to wonder which COVID updated vaccine is best in 2023. Should you go with Pfizer? Moderna? Novavax? Theres a lot going on here.

An important point: Infectious disease doctors stress that the best COVID-19 vaccine is the one youll actually get. That being said, there are a few different things to consider when choosing the right shot for you. Keep this info in mind before you roll up your sleeve.

Meet the experts: Amesh A. Adalja, MD, is a senior scholar at the Johns Hopkins Center for Health Security. Thomas Russo, MD, is a professor and chief of infectious diseases at the University at Buffalo in New York. William Schaffner, MD, is an infectious disease specialist and professor at the Vanderbilt University School of Medicine.

There are three updated COVID vaccines on the market right now:

Worth noting: While plenty of people call these shots boosters, the Centers for Disease Control and Prevention (CDC) and other medical organizations have made it a point to call them updated vaccines since theyre just tweaks to the original vaccine formulas.

The vaccines are different from past versions in the strains of the virus that they target, says Amesh A. Adalja, MD, a senior scholar at the Johns Hopkins Center for Health Security. All of the vaccines differ from prior versions in that they are targeted exclusively against the XBB.1.5 Omicron variant and are not targeted at the ancestral or any other strain, he says.

Otherwise, though, theyre similar to previous vaccines, Russo says.

Nope. You dont need to get the same vaccine, says William Schaffner, MD, an infectious disease specialist and professor at the Vanderbilt University School of Medicine. While some people prefer to go with the same vaccine they originally used, theres no rule that says you have to do this, he says.

Some people want to mix and match the mRNA vaccine with the Novavax vaccine because they think theyll get a broader immune response, he says. But thats still being studied. Meaning, if you got the Pfizer vaccine in the past, some believe you might get even more protection if you try Novavax this time around. Butwe repeatthat's still being studied.

Russo agrees. Grab whatever is available, he says. We dont have any clear indication that one is better than the other.

Doctors say its a good idea to get your updated COVID vaccine ASAP, given that we're now in respiratory virus season. The time to do this was yesterday, Dr. Schaffner says.

If you havent gotten your flu shot yet, its okay to get it at the same time as your COVID vaccine, Adalja says. Just keep in mind that theres a greater risk that youll have side effects if you do this, Russo says. People should use separate arms to minimize the injection site pain, Adalja says.

The CDC stresses that the updated vaccines are safe and effective, noting that hundreds of millions of people in the U.S. received COVID-19 vaccines under the most intense safety monitoring in U.S. history and that the FDA continues to monitor the safety of these vaccines.

Common potential side effects of the vaccine, according to the CDC, include:

The mRNA vaccines have been linked with an increased risk of myocarditis, inflammation of a particular muscle in the heart called the myocardium, but this side effect is rare, Russo says. In fact, the American Heart Association (AHA) says that you have a higher risk of getting myocarditis from COVID-19 than you do from the vaccine.

If youre interested in getting the updated COVID vaccine but have questions, talk to a doctor. They should be able to help give you personalized guidance.

Bottom line: The updated COVID-19 vaccines are now available. According to infectious disease experts, one isnt necessarily better than the otherall that matters is that you get vaccinated.

Korin Miller is a freelance writer specializing in general wellness, sexual health and relationships, and lifestyle trends, with work appearing in Mens Health, Womens Health, Self, Glamour, and more. She has a masters degree from American University, lives by the beach, and hopes to own a teacup pig and taco truck one day.

Read the original post:

Which COVID Booster Should I Get? How To Choose Your Vaccine 2023 - Women's Health

Page 136«..1020..135136137138..150160..»